Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (7): 1000-1006.doi: 10.19982/j.issn.1000-6621.20260112
• Original Articles • Previous Articles Next Articles
Liu Aimei1(
), Liu Sang1, Feng Lizhen2, Wang Qing2
Received:2026-03-05
Online:2026-07-10
Published:2026-07-02
Contact:
Liu Aimei, Email: Supported by:CLC Number:
Liu Aimei, Liu Sang, Feng Lizhen, Wang Qing. Evaluation of surgical outcomes in tuberculosis complicated with HIV/AIDS based on CD4+ T lymphocyte levels[J]. Chinese Journal of Antituberculosis, 2026, 48(7): 1000-1006. doi: 10.19982/j.issn.1000-6621.20260112
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20260112
| 特征 | 合计 (59例) | CD4+ T淋巴细胞计数 <200个/μl组(41例) | CD4+ T淋巴细胞计数 ≥200个/μl组(18例) | χ2值 | P值 |
|---|---|---|---|---|---|
| 年龄组(岁) | 0.372 | 0.542 | |||
| <50 | 32(54.24) | 21(51.22) | 11(61.11) | ||
| ≥50 | 27(45.76) | 20(48.78) | 7(38.89) | ||
| 性别 | 6.142 | 0.013 | |||
| 男性 | 45(76.27) | 35(85.37) | 10(55.56) | ||
| 女性 | 14(23.73) | 6(14.63) | 8(44.44) | ||
| 民族 | 3.053 | 0.081 | |||
| 汉族 | 26(44.07) | 15(36.59) | 11(61.11) | ||
| 其他少数民族 | 33(55.93) | 26(63.41) | 7(38.89) | ||
| 职业 | 6.999 | 0.008 | |||
| 农民/工人 | 48(81.36) | 37(90.24) | 11(61.11) | ||
| 其他 | 11(18.64) | 4(9.76) | 7(38.89) | ||
| 文化程度 | 4.066 | 0.045 | |||
| 大专及以上 | 4(6.78) | 1(2.44) | 3(16.67) | ||
| 高中及以下 | 55(93.22) | 40(97.56) | 15(83.33) | ||
| 手术类型 | 4.940 | 0.026 | |||
| 结核病灶清除手术 | 10(16.95) | 4(9.76) | 6(33.33) | ||
| 非结核病灶清除手术 | 49(83.05) | 37(90.24) | 12(66.67) | ||
| 手术分级 | 5.423 | 0.020 | |||
| Ⅰ/Ⅱ级 | 23(38.98) | 20(48.78) | 3(16.67) | ||
| Ⅲ/Ⅳ级 | 36(61.02) | 21(51.22) | 15(83.33) | ||
| 手术切口分类 | 11.763 | 0.003 | |||
| Ⅰ | 34(57.63) | 29(70.73) | 5(27.78) | ||
| Ⅱ | 9(15.25) | 6(14.63) | 3(16.67) | ||
| Ⅲ | 16(27.12) | 6(14.63) | 10(55.56) | ||
| CD4+/CD8+ T淋巴细胞比值 | 22.475 | <0.001 | |||
| <0.5 | 45(76.27) | 38(92.68) | 7(38.89) | ||
| ≥0.5 | 14(23.73) | 3(7.32) | 11(61.11) | ||
| 红细胞水平 | 4.307 | 0.038 | |||
| 正常 | 34(57.63) | 20(48.78) | 14(77.78) | ||
| 异常 | 25(42.37) | 21(51.22) | 4(22.22) | ||
| 白细胞水平 | 0.123 | 0.726 | |||
| 正常 | 38(64.41) | 27(65.85) | 11(61.11) | ||
| 异常 | 21(35.59) | 14(34.15) | 7(38.89) | ||
| 血红蛋白水平 | 5.668 | 0.017 | |||
| 正常 | 17(28.81) | 8(19.51) | 9(50.00) | ||
| 异常 | 42(71.19) | 33(80.49) | 9(50.00) | ||
| 血小板水平 | 0.094 | 0.759 | |||
| 正常 | 31(52.54) | 21(51.22) | 10(55.56) | ||
| 异常 | 28(47.46) | 20(48.78) | 8(44.44) | ||
| 丙氨酸氨基转移酶 | 0.216 | 0.242 | |||
| 正常 | 47(79.66) | 32(78.05) | 15(83.33) | ||
| 异常 | 12(20.34) | 9(21.95) | 3(16.67) | ||
| 天冬氨酸氨基转移酶 | 9.286 | 0.002 | |||
| 正常 | 39(66.10) | 22(53.66) | 17(94.44) | ||
| 异常 | 20(33.90) | 19(46.34) | 1(5.56) | ||
| 总胆红素水平 | 0.025 | 0.874 | |||
| 正常 | 53(89.83) | 37(90.24) | 16(88.89) | ||
| 异常 | 6(10.17) | 4(9.76) | 2(11.11) | ||
| 直接胆红素水平 | 0.025 | 0.874 | |||
| 正常 | 53(89.83) | 37(90.24) | 16(88.89) | ||
| 异常 | 6(10.17) | 4(9.76) | 2(11.11) | ||
| 白蛋白水平 | 12.413 | <0.001 | |||
| 正常 | 20(33.90) | 8(19.51) | 12(66.67) | ||
| 异常 | 39(66.10) | 33(80.49) | 6(33.33) |
| 指标 | 手术前 | 手术后7d | 手术后14d | 手术后12个月 | 手术后24个月 | χ2值 | P1值 | P2值 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 正常 | 异常 | 正常 | 异常 | 正常 | 异常 | 正常 | 异常 | 正常 | 异常 | |||||
| 红细胞水平 | 34 (57.63) | 25 (42.37) | 25 (42.37) | 34 (57.63) | 33 (55.93) | 26 (44.07) | 44 (74.58) | 15 (25.42) | 43 (72.88) | 16 (27.12) | 17.532 | 0.002 | 9.692 | 0.002 |
| 白细胞水平 | 38 (64.41) | 21 (35.59) | 36 (61.02) | 23 (38.98) | 40 (67.80) | 19 (32.20) | 45 (76.27) | 14 (23.73) | 56 (94.92) | 3 (5.08) | 21.953 | <0.001 | 17.307 | <0.001 |
| 血红蛋白水平 | 17 (28.81) | 42 (71.19) | 18 (30.51) | 41 (69.49) | 20 (33.90) | 39 (66.10) | 46 (77.97) | 13 (22.03) | 50 (84.75) | 9 (15.25) | 77.502 | <0.001 | 59.736 | <0.001 |
| 血小板水平 | 31 (52.54) | 28 (47.46) | 41 (69.49) | 18 (30.51) | 38 (64.41) | 21 (35.59) | 46 (77.97) | 13 (22.03) | 53 (89.83) | 6 (10.17) | 22.551 | <0.001 | 19.637 | <0.001 |
| 丙氨酸氨基转移酶水平 | 47 (79.66) | 12 (20.34) | 48 (81.36) | 11 (18.64) | 53 (89.83) | 6 (10.17) | 53 (89.83) | 6 (10.17) | 52 (88.14) | 7 (11.86) | 4.609 | 0.330 | 3.113 | 0.078 |
| 天冬氨酸氨基转移酶水平 | 39 (66.10) | 20 (33.90) | 43 (77.88) | 16 (27.12) | 47 (79.66) | 12 (20.34) | 50 (84.75) | 9 (15.25) | 53 (89.83) | 6 (10.17) | 12.433 | 0.014 | 12.320 | <0.001 |
| 总胆红素水平 | 53 (89.83) | 6 (10.17) | 52 (88.14) | 7 (11.86) | 57 (96.61) | 2 (3.39) | 56 (94.92) | 3 (5.08) | 58 (98.31) | 1 (1.69) | 7.538 | 0.110 | 5.494 | 0.019 |
| 直接胆红素水平 | 52 (88.14) | 7 (11.86) | 48 (81.36) | 11 (18.64) | 52 (88.14) | 7 (11.86) | 58 (98.31) | 1 (1.69) | 58 (98.31) | 1 (1.69) | 18.185 | 0.004 | 9.705 | 0.002 |
| 白蛋白水平 | 20 (33.90) | 39 (66.10) | 20 (33.90) | 39 (66.10) | 18 (30.51) | 41 (69.49) | 51 (86.44) | 8 (13.56) | 52 (88.14) | 7 (11.86) | 85.106 | <0.001 | 61.494 | <0.001 |
| [1] | 中国疾病预防控制中心性病艾滋病预防控制中心. 2024年12月全国艾滋病性病疫情[J]. 中国艾滋病性病, 2025, 31(3): 225. doi:10.13419/j.cnki.aids.2025.03.01. |
| [2] | 沈佳胤, 卢洪洲. 艾滋病合并结核病的防治研究进展[J]. 中国艾滋病性病, 2015, 21(6): 543-546. doi:10.13419/j.cnki.aids.2015.06.30. |
| [3] | 郑志刚, 耿文奎, 陆珍珍, 等. 艾滋病病毒与结核分枝杆菌双重感染对死亡的影响[J]. 中华流行病学杂志, 2018, 39(10): 1362-1367. doi:10.3760/cma.j.issn.0254-6450.2018.10.014. |
| [4] | Getahun H, Gunneberg C, Granich R, et al. HIV infection-associated tuberculosis: the epidemiology and the response[J]. Clin Infect Dis, 2010, 50 Suppl 3: S201-S207. doi:10.1086/651492. |
| [5] |
Lawn S D, Myer L, Bekker L G, et al. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control[J]. AIDS, 2006, 20(12): 1605-1612. doi:10.1097/01.aids.0000238406.93249.cd.
pmid: 16868441 |
| [6] | Sanguanwongse N, Cain K P, Suriya P, et al. Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand[J]. J Acquir Immune Defic Syndr, 2008, 48(2): 181-189. doi:10.1097/QAI.0b013e318177594e. |
| [7] | Meng S, Tang Q, Xie Z, et al. Spectrum and mortality of opportunistic infections among HIV/AIDS patients in southwestern China[J]. Eur J Clin Microbiol Infect Dis, 2023, 42(1): 113-120. doi:10.1007/s10096-022-04528-y. |
| [8] | 吴金伟, 邓建宁, 吴锋耀, 等. 112例HIV/AIDS病人合并外科疾病的治疗分析[J]. 中国性科学, 2019, 28(12): 106-109. doi:10.3969/j.issn.1672-1993.2019.12.028. |
| [9] | 中华医学会感染病学分会艾滋病学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2024版)[J]. 协和医学杂志, 2024, 15(6): 1261-1288. doi:10.12290/xhyxzz.2024-0766. |
| [10] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断[J]. 结核与肺部疾病杂志, 2024, 5(4): 376-378. doi:10.19983/j.issn.2096-8493.2024022. |
| [11] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017 结核病分类[J]. 结核与肺部疾病杂志, 2024, 5(4): 379-380. doi:10.19983/j.issn.2096-8493.2024055. |
| [12] | 夏咸军, 刘保池. 免疫学指标对人免疫缺陷病毒感染者腹部手术后脓毒症发生的预测作用[J]. 中华胃肠外科杂志, 2011, 14(7): 500-502. doi:10.3760/cma.j.issn.1671-0274.2011.07.007. |
| [13] | World Health Organization. Global tuberculosis report 2025[R]. Geneva: World Health Organization, 2025. |
| [14] | 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 肺结核基层诊疗指南(2018年)[J]. 中华全科医师杂志, 2019, 18(8): 709-717. doi:10.3760/cma.j.issn.1671-7368.2019.08.002. |
| [15] | 丁晨, 张娜, 靳廷丽, 等. 新报告HIV感染者/AIDS基线病毒载量水平与CD4+/CD8+比值分析[J]. 现代预防医学, 2022, 49(21): 4014-4019. doi:10.20043/j.cnki.MPM.202204399. |
| [16] | 张娜, 朱晓楠, 王国永, 等. 山东省抗病毒治疗HIV/AIDS生存状况及影响因素分析[J]. 中华流行病学杂志, 2019, 40(1): 74-78. doi:10.3760/cma.j.issn.0254-6450.2019.01.015. |
| [17] | Bell L C K, Noursadeghi M. Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection[J]. Nat Rev Microbiol, 2018, 16(2): 80-90. doi:10.1038/nrmicro.2017.128. |
| [18] |
Khanna K, Sabharwal S. Spinal tuberculosis: a comprehensive review for the modern spine surgeon[J]. Spine J, 2019, 19(11): 1858-1870. doi:10.1016/j.spinee.2019.05.002.
pmid: 31102727 |
| [19] | 袁雄辉, 潘瑞康, 张剑. 脊柱结核术后手术部位感染危险因素分析[J]. 中国医学创新, 2023, 20(14): 130-133. doi:10.3969/j.issn.1674-4985.2023.14.031. |
| [20] | Mandalakas A M, Kay A W, Bacha J M, et al. Tuberculosis among Children and Adolescents at HIV Treatment Centers in Sub-Saharan Africa[J]. Emerg Infect Dis, 2020, 26(12): 2933-2943. doi:10.3201/eid2612.202245. |
| [21] |
Shivakoti R, Yang W T, Gupte N, et al. Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation[J]. Clin Infect Dis, 2015, 61(1): 102-110. doi:10.1093/cid/civ265.
pmid: 25828994 |
| [22] | Demitto F O, Araújo-Pereira M, Schmaltz C A, et al. Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV[J]. Front Immunol, 2020, 11: 588405. doi:10.3389/fimmu.2020.588405. |
| [23] | 张敏, 黄兵, 付天学. HIV感染者/AIDS患者外科手术后的临床观察[J]. 中国热带医学, 2019, 19(6): 566-570. doi:10.13604/j.cnki.46-1064/r.2019.06.16. |
| [24] | Tran L M, Cong G, Eslami M H, et al. Symptomatic human immunodeficiency virus infection is associated with advanced presentation and perioperative mortality in patients undergoing surgery for peripheral arterial disease[J]. J Vasc Surg, 2022, 75(4): 1403-1412.e2. doi:10.1016/j.jvs.2021.09.034. |
| [25] |
Kim T I, Brahmandam A, Sarac T P, et al. Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization[J]. Vasc Med, 2020, 25(6): 527-533. doi:10.1177/1358863X20952856.
pmid: 33019909 |
| [26] | Varshneya K, Wadhwa H, Ho A L, et al. Surgical Outcomes of Human Immunodeficiency Virus-positive Patients Undergoing Lumbar Degenerative Surgery[J]. Clin Spine Surg, 2022, 35(2): E339-E344. doi:10.1097/BSD.0000000000001221. |
| [27] | 王正力, 吴德利, 吴晓明, 等. HIV合并外科疾病手术相关感染危险因素研究[J]. 现代医药卫生, 2023, 39(14): 2412-2416. doi:10.3969/j.issn.1009-5519.2023.14.014. |
| [1] | Guo Xiaowen, Jiao Tianyu, Sun Li, Ni Conghui, Wang Zilin, Wang Hao. Multi-center study on CE-T1WI radiomics-based machine learning model in differentiating tuberculous spondylitis from brucella spondylitis [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1184-1191. |
| [2] | Lyu Yongyun, Li Xiaoqin, Wu Mengtai, Zhou Min, Tian Nan, Shen Ling. Study on hospitalization cost and its influencing factors of pulmonary tuberculosis under the diagnosis-related group payment model [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1205-1213. |
| [3] | Yang Yueqi, Fu Linlin, He Lanfang, Cao Yuanlin, Yu Sihan, Zhang Yingfang, Xia Tongxia. Research progress on influencing factors and management strategies of medical delay in patients with spinal tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1226-1230. |
| [4] | Sun Danyuchen, Liu Yuhong. Pharmacotherapy of rifampicin-resistant/multidrug-resistant tuberculosis: advances and prospects in health economic research [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1231-1230. |
| [5] | Gao Qian. Rational return to non-sputum screening for tuberculosis: inherent limitations and reconsideration of the position of tongue swabs [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1120-1123. |
| [6] | Liao Wenping, Zhang Liyi, Lyu Juan, Xin Yu, Su Qian, Zhang Wen. Association between magnitude of tuberculin skin test reactions and risk of pulmonary tuberculosis among senior high school students [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1124-1129. |
| [7] | Liu Zisen, Zhao Yaqi, Zhang Bin, Xin Henan, Du Jiang, Feng Boxuan, He Yijun, Li Zihan, Yu Yilin, Wang Dakuan, Yan Jiaoxia, Gao Lei, Jin Qi, Duan Weitao, Cao Xuefang. Analysis of re-screening for latent tuberculosis infection in 2025 and related factors affecting infection status among rural doctors in Zhongmu County, Henan Province, based on 2017 screening [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1139-1147. |
| [8] | Li Xinda, Hou Zhili, Ouyang Bing, Du Yadong, Guan Liying, Yu Hongmei, Zhang Haiqin, Xie Yongjie, Tang Peijun, Xiao Yu, Zhang Ying, Lu Yu. Evaluation of safety and efficacy of anti-tuberculosis fixed-dose combination in patients with drug-susceptible pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1158-1162. |
| [9] | Qi Yunfeng, Wang Xueyu, Kang Wanli, Nie Wenjuan, Wang Yiwen. The application value of tongue swab nucleic acid testing in the diagnosis of suspected tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1163-1169. |
| [10] | Zeng Lina, Li Wensi, Lu Hailin, Wang Wenfei, Chen Xinchun, Deng Guofang, Xie Shuixiang. Advances in Mycobacterium tuberculosis regulation of host lipid metabolism reprogramming [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1214-1219. |
| [11] | Standardization Professional Branch of Chinese Antituberculosis Association, Tuberculosis Infect Control Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Guidelines for the application of tuberculin skin test [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1083-1095. |
| [12] | Wang Xiaomin, Xu Peng, Chen Zhenyan, Long Yujiao, Wang Jin, Liu Han, Gao Wenying, Fang Mutong. Interpretation of the Guidelines for the prevention and management of mother-to-child transmission of tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1113-1119. |
| [13] | Guo Jinlong, Min Xuhong, Song Biao, Li Yuan, Wang Shanghu, Chen Wu. Imaging feature analysis of pseudo-pulmonary embolism on dual-phase computed tomography angiography in pulmonary tuberculosis patients with bronchial-pulmonary shunts [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1192-1198. |
| [14] | Ding Guangzhao, Liu Rongmei. Cell-free RNA liquid biopsy for stratified diagnosis and dynamic monitoring of tuberculosis: research progress and translational challenges [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1220-1225. |
| [15] | Xia Hongli, Hua Jiao, Lu Jiankang. Investigation results and analysis of associated factors of tuberculosis infection and disease among school students in Xichang City, Sichuan Province, 2023 [J]. Chinese Journal of Antituberculosis, 2026, 48(8): 1130-1138. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.